64 participants
HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-12-30
- Start Date:
- 2022-11-10
- Completion:
- 2025-12-23
Conditions
- Liver Cancer
Interventions
- COMBINATION_PRODUCT
No Results Yet